Evidence map›Paper›PMID 35348190›Full record

ArticleInternational journal of molecular medicine2022

2,3,4',5‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside ameliorates gentamicin‑induced ototoxicity by modulating autophagy via Sesn2/AMPK/mTOR signaling.

Yu-Hsuan Wen, Hui-Yi Lin, Jia-Ni Lin, Guo-Fang Tseng, Chung-Feng Hwang, Chung-Ching Lin, Chuan-Jen Hsu, Hung-Pin Wu

Open access · hybridAbstract read
In one paragraph

Article in International journal of molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yu-Hsuan WenInstitute of Medical Sciences, Tzu Chi University, Hualien 970374, Taiwan, R.O.C.
Hui-Yi LinSchool of Pharmacy, College of Pharmacy, China Medical University, Taichung 404328, Taiwan, R.O.C.
Jia-Ni LinDepartment of Otolaryngology, Head and Neck Surgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427213, Taiwan, R.O.C.
Guo-Fang TsengInstitute of Medical Sciences, Tzu Chi University, Hualien 970374, Taiwan, R.O.C.
Chung-Feng HwangDepartment of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833401, Taiwan, R.O.C.
Chung-Ching LinDepartment of Otolaryngology, Head and Neck Surgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427213, Taiwan, R.O.C.
Chuan-Jen HsuDepartment of Otolaryngology, Head and Neck Surgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427213, Taiwan, R.O.C.
Hung-Pin WuInstitute of Medical Sciences, Tzu Chi University, Hualien 970374, Taiwan, R.O.C.
Taipei Tzu Chi Hospital · TWTzu Chi University · TWChina Medical University · TWKaohsiung Chang Gung Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gentamicin is an important aminoglycoside antibiotic used in the treatment of gram‑negative bacterial infections, but nephrotoxicity and ototoxicity reduce its utility. The autophagy pathway is involved in damage of auditory hair cells. With the aim of developing new strategies for attenuating gentamicin ototoxicity, the present study investigated the otoprotective mechanism of 2,3,4',5‑tetrahydroxystilbene‑2‑O‑β‑D-glucoside (THSG)

Indexed as

OtotoxicityAMP-Activated Protein KinasesAnimalsAutophagyGentamicinsGlucosidesMiceStilbenesTOR Serine-Threonine Kinases2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranosideAMP-Activated Protein KinasesGentamicinsGlucosidesStilbenesTOR Serine-Threonine Kinases234'5‑tetrahydroxystilbene‑2-O‑β‑D‑glucosideautophagygentamicinototoxicityUB/OC‑2 cochlear cells

Identifiers

PMID35348190
PMCPMC8989425
OpenAlexW4221028535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.